METTL3/14 Complex (human, recombinant)

METTL3/14 Complex (human, recombinant)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
Cay26342-50 50 µg -

6 - 10 Werktage*

758,00 €
 
Methyltransferase-like protein 3 (METTL3) and METTL14 are m6A RNA methyltransferases encoded by... mehr
Produktinformationen "METTL3/14 Complex (human, recombinant)"
Methyltransferase-like protein 3 (METTL3) and METTL14 are m6A RNA methyltransferases encoded by the METTL3 and METTL14 genes, respectively, in humans. METTL3 and METTL14 form a stable complex in the cytoplasm then localize to the nucleus via a METTL3 nuclear localization sequence. METTL3 contains an N-terminal leader helix domain that interacts with Wilms' tumor 1-associated protein (WTAP) in the nucleus, which confers localization of the complex to nuclear speckles. METTL14 contains a C-terminal arginine-glycine-glycine (RGG) sequence that contributes to the catalytic activity of the complex. METTL3 and METTL14 each contain methyltransferase domains but the METTL3 domain alone binds S-adenosylmethionine (SAM) or S-adenosylhomocysteine (SAH) while METTL14 interacts with RNA. The METTL3/14 complex primarily binds to regions of RNA that correspond to intergenic and intron regions of DNA, and it preferentially methylates RNA substrates that contain the sequence GGACU, with little preference for secondary structural features of the substrates. METTL3 and METTL14 are involved in hematopoietic stem cell differentiation in vitro and are necessary for self-renewal and reconstitution of hematopoietic stem cells following bone marrow transplantation in mice. Mettl3 knockdown or Mettl14 knockout increases radial glia cell cycle length in embryonic mouse brain, and Mettl14 knockout extends cortical neurogenesis into the postnatal period. Knockdown of METTL3 or METTL14 also increases proliferation of glioblastoma stem cells (GSCs) in vitro and increases tumor size in a mouse orthotopic model using GSCs. The expression of METTL3 and METTL14 is reduced in juvenile patients with ETV6/RUNX1(E/R)-positive acute lymphoblastic leukemia (ALL).Synonyms: hMETTL3/hMETTL14, Methyltransferase-like Protein 3/Methyltransferase-like Protein 14, N6-Adenosine-Methyltransferase Catalytic Subunit/N6-Adenosine-Methyltransferase Non-catalytic Subunit. Purity: >80% estimated by SDS-PAGE. Source: Recombinant human N-terminal histidine-tagged METTL3 and recombinant human N-terminal GST-histidine-tagged METTL14 expressed in insect cells. Amino Acids: 2-580 and 2-456 for METTL3 and METTL14, respectively. MW: 66.3 and 79.1 kDa for METTL3 and METTL14, respectively. Formulation: (Request formulation change), 10 mM Tris, with 500 mM sodium chloride, 1 mM DTT, and 5% glycerol. UniProt Accession #: Q86U44 and Q9HCE5.
Schlagworte: hMETTL14, hMETTL14, Methyltransferase-like protein 14, Methyltransferase-like protein 14, N6-adenosine-methyltransferase non-catalytic subunit, N6-adenosine-methyltransferase non-catalytic subunit
Hersteller: Cayman Chemical
Hersteller-Nr: 26342

Eigenschaften

Anwendung: WB
Konjugat: No
Reinheit: >80% estimated by SDS-PAGE
Format: Solution

Handhabung & Sicherheit

Lagerung: -80°C
Versand: -80°C (International: -80°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "METTL3/14 Complex (human, recombinant)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen